ACE inhibitor-induced acute renal failure in a patient with progressive systemic sclerosis: Ischemic nephropathy mimicking PSS renal crisis

Internal Medicine

Volumn 46, Issue 18, 2007, Pages 1605-1607

  Shinohara, Miho ^a   Washida, Naoki ^a   Tanaka, Atsuo ^a   Ueda, Satoshi ^a   Kuwahara, Takashi ^a   Kojima, Hirohisa ^b  

^a SAISEIKAI NAKATSU HOSPITAL   (Japan)

^b Saiseikai Shinsennan Hospital   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Atherosclerotic renal artery stenosis; Ischemic nephropathy; PSS renal crisis

Indexed keywords

AMLODIN; AMLODIPINE BESYLATE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL MALEATE; FUROSEMIDE; GLYCERYL TRINITRATE; NICARDIPINE; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CASE REPORT; CLINICAL FEATURE; DISEASE EXACERBATION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY ISCHEMIA; LABORATORY TEST; LUNG FIBROSIS; MAGNETIC RESONANCE ANGIOGRAPHY; PHYSICAL EXAMINATION; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME; URINALYSIS;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KIDNEY; KIDNEY FAILURE, ACUTE; SCLERODERMA, DIFFUSE;

EID: 34948898119     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0118     Document Type: Article

References (8)

1. Steen VD, Constantino JP, Shapiro AP, Medsger TA Jr. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 113: 352-357, 1990.
2. Schoolwerth AC, Sica DA. Ballermann BJ, Wilcox CS. Renal considerations in angiotensin-converting enzyme inhibitor therapy. A statement for healthcare professionals from the council on the kidney in cardiovascular disease and the council for high blood pressure research of the American Heart Association. Circulation 104: 1985-1991, 2001.
3. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23: 581-590, 1980.
4. Hasegawa S, Iesato K, Tsukahara T, et al. Successful use of angiotensin II receptor antagonist (losartan) in a patient with scleroderma renal crisis (in Japanese, Abstract in English). Nippon Jinzo Gakkai Shi 42: 60-65, 2000.
5. Breyer JA, Jacobson HR. Ischemic nephropathy. Curr Opin Nephrol Hypertens 2: 216-224, 1993.
6. Textor SC. Ischemic nephropathy: where are we now? J Am Soc Nephrol 15: 1974-1982, 2004.
7. Preston RA, Epstein M. Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease. J Hypertens 15: 1365-1377, 1997.
8. Tzivoni D. End organ protection by calcium-channel blockers. Clin Cardiol 24: 102-106, 2001.